Trials / Conditions / Checkpoint Inhibitor
Checkpoint Inhibitor
5 registered clinical trials studyying Checkpoint Inhibitor — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot Stu NCT07257068 | M.D. Anderson Cancer Center | N/A |
| Not Yet Recruiting | SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitor NCT07341321 | Medical University of Graz | — |
| Completed | Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC NCT04507906 | Shanghai Chest Hospital | Phase 1 / Phase 2 |
| Completed | Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease NCT04805099 | Hellenic Cooperative Oncology Group | — |
| Completed | Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic Modelli NCT06298123 | Chen Xiaoping | — |